Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Browsing Tag

STAT+

46 posts
RRoche
FDA approves new breast cancer drug, a new option for some patients
Read More

FDA approves new breast cancer drug, a new option for some patients

  • 2026-11-16
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
NNovartis
Zolgensma gene therapy link to tumor risk 'will change the calculus'
Read More

Zolgensma gene therapy link to tumor risk ‘will change the calculus’

  • 2026-11-10
For two decades, researchers debated whether adeno-associated viruses, the small viruses used to deliver new genes into thousands…
NNovartis
Pharmalittle: Novartis abandons heart drug, BIO fights Medicare pilot
Read More

Pharmalittle: Novartis abandons heart drug, BIO fights Medicare pilot

  • 2026-11-09
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating,…
NNovartis
Lp(a) drug lowers heart risk marker but not adverse heart events
Read More

Lp(a) drug lowers heart risk marker but not adverse heart events

  • 2026-11-07
CHICAGO — Lipoprotein(a), a genetic risk factor for cardiovascular disease carried by 1 in 5 people, is the…
NNovartis
Pharmalittle: Tumors found in kids treated with Novartis SMA drug
Read More

Pharmalittle: Tumors found in kids treated with Novartis SMA drug

  • 2026-11-06
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
NNovartis
Novartis cites previously unknown tumor cases possibly tied to gene therapy
Read More

Novartis cites previously unknown tumor cases possibly tied to gene therapy

  • 2026-11-05
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
NNovartis
Novartis cites previously unknown tumor cases possibly tied to gene therapy
Read More

Novartis cites previously unknown tumor cases possibly tied to gene therapy

  • 2026-11-05
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
RRoche
Roche's lung cancer drug divarasib shows impressive data
Read More

Roche’s lung cancer drug divarasib shows impressive data

  • 2026-10-26
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
RRoche
Pharmalittle: Roche reports lung cancer data; CAR-T trial death noted
Read More

Pharmalittle: Roche reports lung cancer data; CAR-T trial death noted

  • 2026-10-26
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating…
NNovartis
Novartis MS treatment cuts rates of relapse in pivotal trials
Read More

Novartis MS treatment cuts rates of relapse in pivotal trials

  • 2026-10-23
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
RRoche
Pharmalittle: U.S-China biotech deals to get added scrutiny
Read More

Pharmalittle: U.S-China biotech deals to get added scrutiny

  • 2026-10-22
Top of the morning to you.  Blue skies, cool breezes, and plenty of chirping birds are enveloping the…
NNovartis
Muscular dystrophy therapy is available, but only to a fortunate few
Read More

Muscular dystrophy therapy is available, but only to a fortunate few

  • 2026-10-08
There’s a boy like you in Minnesota, Yannick’s mom told him a few years ago. He has the…
Switzerland
www.europesays.com